Table 1.
Treatment groups | Formulation | Particle Size (nm) | PdI | Zeta potential (mV) |
---|---|---|---|---|
Peptide + CpG | GP100 + CpG | 166.7 ± 5.42 | 0.287 ± 0.10 | - 6.42 ± 0.00 |
Lip-peptide | DOTAP: Chol: GP100 | 231.5 ± 3.04 | 0.315 ± 0.01 | 6.15 ± 3.09 |
Lip-peptide + CpG | DOTAP: Chol: GP100 + CpG | 277.7 ± 3.83 | 0.226 ± 0.06 | -3.76 ± 6.14 |